Norbert Gruenfeld is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive and cardioactive agents. With a total of 8 patents to his name, Gruenfeld's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents are the 1-mercaptoalkanoylindoline-2-carboxylic acids. These compounds, which include functional derivatives, are recognized for their potential as antihypertensive and cardioactive agents. Another significant patent is for 1-carboxyalkanoylindoline-2-carboxylic acids, which also showcases various functional groups that enhance their therapeutic properties.

Career Highlights

Norbert Gruenfeld has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work at the company has allowed him to focus on innovative solutions for cardiovascular health. Gruenfeld's research and development efforts have contributed to advancements in drug formulations that address hypertension.

Collaborations

One of his notable collaborators is James L Stanton. Their partnership has fostered a productive environment for innovation and has led to the successful development of several key patents.

Conclusion

Norbert Gruenfeld's contributions to the field of pharmaceuticals, particularly in antihypertensive agents, highlight his role as a significant inventor. His ongoing work continues to influence medical advancements and improve patient care.